tradingview.comOct 30$DXC

JP Morgan maintains DXC Technology at Underweight, raises price target to $13 from $12

JP Morgan kept its Underweight rating on DXC Technology but increased its price target to $13 from $12, suggesting a 13.2% downside from the last close of $14.98.

Original reporting

tradingview.com

Published Oct 30, 2026, 10:33 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 30, 2026, 10:39 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

JP Morgan maintains DXC Technology at Underweight, raises price target to $13 from $12 — source image — Source · tradingview.com

Decision brief

The 30-second read

$DXCBullishMed

Why it matters

The upgrade could attract new buyers and support a short‑term price gain.

Market read

Analyst upgrade provides a fresh catalyst for DXC, modestly bullish for the stock.

What to watch

Potential downside from broader tech sector weakness could offset the upgrade.

Relevance 5/10Novelty 5/10Timing: today

Background

JP Morgan's rating change is part of its regular coverage of DXC Technology.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$DXCBullishMedium confidence

Context

JP Morgan raised its price target for DXC Technology to $13 from $12, indicating a fresh analyst upgrade.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target suggests upside of ~13% from current price, prompting short‑term buying interest.

Market effects

Sector

May lift sentiment for the broader IT services sector.

Regional

Limited to US equity markets.

Global

Low

Counterpoint

What could challenge this read

The target increase is modest; price may already reflect the upside.

Key entities

company
DXC Technology
US‑listed IT services firm (ticker DXC).
analyst
JP Morgan
Investment bank providing the rating and price target.

Read at source ← All news

$ACNHighAI 8/10

Q3 earnings outperformers: Accenture (NYSE:ACN) and the rest of the IT services & consulting stocks

Accenture (NYSE:ACN) and peers reported Q3 earnings, with Accenture beating revenue estimates by 3.5% and Gartner (NYSE:IT) outperforming by 1.2%. DXC (NYSE:DXC) missed EPS guidance. IBM (NYSE:IBM) and Kyndryl (NYSE:KD) also reported, with mixed results. IT services & consulting stocks are up 11.4% on average since earnings.

stockstory.orgNov 10

$DXCHighAI 8/10

What DXC Technology (DXC) Said on Its Q2 Earnings Call

DXC Technology reported Q2 earnings, with CES revenue down 3.3% YoY and GIS revenue down 10%. Insurance revenue grew 23% YoY, driven by a one-time contract. DXC reduced its fiscal 2027 outlook, expecting full-year organic revenue to decline 5% to 5.5% YoY. The company generated $91M in free cash flow, excluding a $122M tax-related payment. DXC is focusing on AI and cybersecurity growth.

finance.yahoo.comOct 30

$DXCHighAI 8/10

DXC Technology Co (DXC) (Q2 2027) Earnings Call Highlights: Revenue Beats Guidance

DXC Technology (DXC) reported Q2 2027 revenue beating guidance but lowered full-year revenue outlook to a 5-5.5% decline due to weak bookings and pipeline conversion. Adjusted EBIT margin fell to 6.2%, and non-GAAP EPS dropped to $0.67. The company faces deal delays and increased competition, particularly in the Americas and UKI. DXC is taking cost actions to protect margins but revenue decline may pressure future profitability.

finance.yahoo.comOct 30

$DXCMed

Susquehanna maintains DXC Technology at Neutral, raises price target to $12 from $10

Susquehanna kept DXC Technology at Neutral but raised its price target to $12 from $10, a 20% increase. This implies a 21.2% downside from the Oct 29 close of $15.23, according to the firm.

tradingview.comOct 30

$DXCHighAI 9/10

Why is DXC Technology stock tumbling today?

DXC Technology (DXC) stock fell 12.3% in pre-market trading after reporting mixed Q2 results. While EPS ($0.67) and revenue ($3.03B) beat estimates, the company lowered FY2027 guidance, citing weak demand and execution issues. CEO Raul Fernandez attributed some weakness to 'sales execution.' Susquehanna maintained a Neutral rating with a $12 price target. The stock traded at $13.35, nearing its 52-week low.

investing.comOct 30